Related Experiment Videos
New molecular surface-based 3D-QSAR method using Kohonen neural network and 3-way PLS.
Kiyoshi Hasegawa1, Shigeo Matsuoka, Masamoto Arakawa
1Nippon Roche, Kajiwara, Kamakura, Japan.
Computers & Chemistry
|October 19, 2002
Summary
A novel surface-based 3D-QSAR method using Kohonen neural networks and three-way PLS improves predictions for dopamine 2 receptor antagonists. This approach offers more realistic ligand-receptor interaction modeling than standard CoMFA.
Area of Science:
- Computational Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Comparative molecular field analysis (CoMFA) is a standard 3D-QSAR method but may not accurately reflect ligand-receptor interactions.
- Key molecular interactions occur near the van der Waals surface, suggesting grid points surrounding the entire molecule in CoMFA are not always relevant.
Purpose of the Study:
- To develop a more precise and realistic 3D-QSAR method by focusing on physico-chemical parameters on the molecular surface.
- To introduce a surface-based 3D-QSAR approach utilizing Kohonen neural network (KNN) and three-way partial least squares (3-way PLS).
Main Methods:
- Developed a surface-based 3D-QSAR method integrating KNN and 3-way PLS.
- Applied the method to 25 dopamine 2 (D2) receptor antagonists.
- Projected 3D van der Waals surface points to a 2D map using KNN, coded nodes with molecular electrostatic potential (MEP) values, and analyzed correlations with D2 antagonist activities using 3-way PLS.
Main Results:
- The 3-way PLS model demonstrated excellent statistics.
- Coefficients back-projected onto the van der Waals surface showed a reasonable 3D distribution.
- External validation using D-optimal designs indicated superior predictive performance of 3-way PLS compared to standard 2-way PLS.
Conclusions:
- The developed surface-based 3D-QSAR method provides a more realistic representation of ligand-receptor interactions.
- This novel approach enhances the predictive accuracy of 3D-QSAR models for drug discovery, particularly for D2 receptor antagonists.
- Three-way PLS offers improved predictive capabilities over traditional 2-way PLS in external validation scenarios.